$VERX

Vertex Announces Second Quarter 2026 Financial Results

Vertex, Inc. (NASDAQ: VERX) reported Q2 2026 results for the quarter ended June 30, 2026. Total revenue rose 10.5% to $204.0 million, with software subscription revenue up 10.7% to $174.8 million and cloud revenue up 17.9% to $101.7 million. Adjusted EBITDA increased to $51.0 million. Outlook: Q3 revenue $208.0-$211.0 million and adjusted EBITDA $55.0-$57.0 million; FY 2026 revenue $825.0-$830.0 million and adjusted EBITDA $206.0-$210.0 million.

Original reporting
Published Aug 4, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 12:38 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$VERX
Bullish
medium confidence
Mentioned
$VERX
Relevance
8/10
alphai data visualization · based on itnewsonline.com
Decision brief

The 30-second read

$VERXBullishMed
01

Why it matters

Traders can update models using the provided Q2 metrics (revenue, ARR, NRR/GRR, adjusted EBITDA) and the explicit Q3 and FY 2026 ranges. The key debate is whether cloud and e-invoicing momentum sustain margin expansion into 3Q and 4Q.

02

Market read

A company-specific earnings and guidance release with explicit profitability and growth targets, likely driving near-term repricing versus prior expectations.

03

What to watch

Operating loss from operations remains negative (-$4.4M), and the company highlights inability to reconcile Adjusted EBITDA to GAAP net income, which can matter for investors focused on GAAP profitability and cash conversion.

Relevance 8/10Novelty 8/10Timing: pre-market/market open context for Aug 3, 2026 earnings call and same-day guidance digestion

Background

Vertex, an indirect tax and compliance software provider, reported Q2 2026 results and issued Q3 and full-year 2026 guidance, alongside commentary on an AI-First transformation.

Company-level read

Ticker impact

$VERXBullishMedium confidence
Context

Vertex reported Q2 2026 revenue of $204.0M (+10.5% YoY) and raised/narrowed outlook with Q3 adjusted EBITDA of $55.0M to $57.0M.

Expected impact

Likely positive bias for the next session and into Q3 as traders price in higher profitability and cash-generation expectations.

Evidence & confidence

The release provides multiple decision-useful datapoints: revenue at high end of guidance, adjusted EBITDA above expectations, and explicit Q3 and FY 2026 ranges. However, the article does not include consensus comparisons or prior guidance levels, limiting precision on upside surprise magnitude.

Market effects

Signals continued demand for indirect tax and compliance software, with e-invoicing momentum and cloud growth supporting the SaaS compliance peer group’s growth narrative.

Limited direct regional read-through; primarily a US-listed software earnings signal with global customer mandate tailwinds.

E-invoicing and expanding global compliance mandates are referenced as drivers, which can influence broader cross-border compliance software sentiment.

Counterpoint

NRR is flat at 105% and GRR is 95%, so growth may be more about expansion within the base than net customer quality improvement.

Key entities

  • Vertex, Inc.

    NASDAQ-listed indirect tax and compliance software company reporting Q2 2026 results and guidance.

  • Christopher Young

    CEO quoted on Q2 performance, AI-First strategy progress, and operating discipline.

  • John Schwab

    CFO quoted on narrowing revenue guidance range and raising adjusted EBITDA outlook.

Related articles

$VERXMedAI 8/10

Vertex Q2 Earnings Call Highlights

Vertex (NASDAQ:VERX) said slower cloud conversion is a timing issue, with customers using mixed cloud and on-prem deployments. Management highlighted strong e-invoicing momentum ahead of France and Germany mandates, expecting e-invoicing to affect ARR in Q3 and more in Q4. Q3 guidance: revenue $208M-$211M, adj. EBITDA $55M-$57M; full-year revenue $825M-$830M and adj. EBITDA $206M-$210M.

$VERXMedAI 8/10

Why is Vertex stock sliding today?

Vertex Pharmaceuticals shares fell 12.8% after its post-close Q2 2026 results. The company reported EPS of $0.20 vs $0.19 consensus and revenue of $203.97M vs $202.29M forecast, but Q3 2026 revenue guidance of $208M-$211M (midpoint below ~$211.69M consensus) and free cash flow of $2.7M disappointed. Morgan Stanley downgraded to Equal Weight and cut its price target to $15 from $19.

$VERXMed

Vertex stock tumbles on cloud growth miss, price target cuts

Vertex Inc. (NASDAQ:VERX) shares dropped 13.2% after its Q2 results missed cloud growth expectations and analysts cut price targets. DA Davidson lowered its target to $12 from $15, citing slower cloud conversions and reduced FY26 cloud growth guidance to 18% from 25%. Other analysts also adjusted targets following guidance and deal-cycle comments.

$VERXHigh

Vertex, Inc. (VERX): Results of Operations and Financial Condition

Vertex, Inc. (VERX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 verx-20260803xex99d1.htm EX-99.1 ​ Exhibit 99.1 Vertex Announces Second Quarter 2026 Financial Results KING OF PRUSSIA, PA – August 3, 2026: Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), the Decision-to-Defense™ global indirect tax and compliance company, tod